Medicine
Maraviroc 300 mg tablet
Maraviroc 300 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Bottle of 60 tablets (NDC 31722-580-60) Maraviroc film-coated tablets should…
Key facts
- Active ingredient (INN)
- Maraviroc
- Brand
- Sold under the generic name
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets and 5 more
- Manufacturers
- Camber PharmaceuticalsIndiaZydus LifesciencesIndiaA-S Medication SolutionsA2A Integrated Pharmaceuticalsi3 PharmaceuticalsNavintaRhodes PharmaceuticalsXLCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Bottle of 60 tablets (NDC 31722-580-60) Maraviroc film-coated tablets should be stored at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AX09 Maraviroc
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 February 2022
- Identifiers
- RxCUI 728223, 728225DailyMed set ID 09ec3e79-c0d3-4b8f-80d8-0a854c4ca339, c35f72dc-d90e-43f8-9899-f7d1da89460d, 9bba17ba-0bc5-430c-96d1-c568e236a0ed +5NDC 31722-580, 42858-247, 70710-1931 +5Application ANDA203347, ANDA216143, ANDA217880 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, film coated in 1 bottle | 31722-580-60 | Camber PharmaceuticalsIndia | 6 February 2022 |
| 60 tablet, film coated in 1 bottle | 70710-1931-6 | Zydus LifesciencesIndia | 23 May 2025 |
| 60 tablet, film coated in 1 bottle | 73141-025-02 | A2A Integrated Pharmaceuticals | 16 May 2024 |
| 60 tablet, film coated in 1 bottle | 72319-025-02 | i3 Pharmaceuticals | 15 September 2023 |
| 60 tablet, film coated in 1 bottle | 68475-007-01 | Navinta | 23 June 2025 |
| 60 tablet, film coated in 1 bottle, plastic | 42858-247-06 | Rhodes Pharmaceuticals | 30 September 2026 |
| 60 tablet, film coated in 1 bottle | 72865-232-60 | XLCare Pharmaceuticals | 1 June 2023 |
| 60 tablet, film coated in 1 bottle | 50090-8005-0 | A-S Medication Solutions | 25 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Maraviroc 300 mg tablet.
Other strengths and forms of Maraviroc
Clinical summary
Maraviroc is a CCR5 Co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 2 kg. MedsAcross supplies Maraviroc for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MaravirocFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SELZENTRY prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Celsentri: European public assessment report (EPAR) · European Medicines Agency
Need Maraviroc 300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.